Lea Louise Volmer

5PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersRehabilitation engineeringMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 29, 2026
Real-Time Electronic Patient-Reported Outcome Monitoring With Digital Triage and Care-Team Integration in Early Breast Cancer: ENABLE Randomized Controlled Trial.

|Jun 11, 2025
Correction: ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial.

Thomas M Deutsch, Léa L Volmer, Manuel Feisst

|May 26, 2025
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial.

Thomas M Deutsch, Léa L Volmer, Manuel Feisst

|Aug 27, 2024
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations.

Hannes Armbruster, Tilman Schotte, Isabell Götting

|Aug 09, 2023
Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial.

Léa L Volmer, Dominik Dannehl, Tobias Engler

Pageof 1

Frequent Collaborators

4 joint publications

Andreas D Hartkopf

4 joint publications

Tobias Engler

3 joint publications

Thomas M Deutsch

3 joint publications

Manuel Feisst